The partners will collaborate to empower the lung cancer community through educational efforts.
CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, welcomes Lung Cancer Alliance to its Strategic Alliance Partnership (SAP) Program.
“Countless individuals across the nation are affected by lung cancer,” said Michael J. Hennessy Jr., president of CURE Media Group. “We are proud to partner with Lung Cancer Alliance to continue to empower the lung cancer community through our ongoing efforts to identify novel treatment approaches by providing relevant information.”
Founded in 1995, Lung Cancer Alliance is one of the nation’s leading non-profit health organizations committed to serving the lung cancer community. Lung Cancer Alliance empowers a vibrant and caring community by helping people navigate the paths of early detection, diagnosis, treatment and long-term survival. Lung Cancer Alliance leverages insights into the lung cancer community to improve care, amplify awareness, drive advocacy and lead transformative research with the vision of tripling the number of survivors in the next decade.
“We are excited to partner with CURE Media Group,” said Laurie Fenton Ambrose, President and CEO of Lung Cancer Alliance. “This collaboration will allow us to pursue better outcomes for our community by improving access to resources that patients and loved ones need in their fight against the number one cancer killer no matter where they are in their journey.”
As part of this joint effort, Lung Cancer Alliance will be able to share valuable content through CURE® magazine, where readers will have access to unprecedented resources including the latest research, interviews and articles that can help patients with cancer, and their caregivers, make better informed decisions. The SAP Program is designed to facilitate an open exchange of information among trusted peers, with the goal to improve patient care.
For more information about the SAP Program, visit https://www.curetoday.com/advocacy/partners.
CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry-leading website, CUREtoday.com; innovative video programs, such as CURE Connections®; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers. CURE Media Group is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses, which includes the acclaimed OncLive®(http://www.www.onclive.com) platform of resources for the practicing oncologist. For more information, visit http://www.curetoday.com or http://www.mjhassoc.com.
FDA Approves Amivantamab-Chemo Combo for Advanced NSCLC
September 19th 2024The FDA approved amivantamab-vmjw plus chemotherapy for locally advanced or metastatic non–small cell lung cancer (NSCLC) that harbors EGFR exon 19 deletions or exon 21 L858R substitution mutations whose disease has progressed on or after treatment with an EGFR TKI.